Elixxer’s Investment in Italian Medical Cannabis (Evolution BNK) Shows Significant Revenue Growth
Montreal, Quebec--(Newsfile Corp. - February 10, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is proud...
Month: February 2022
CBD of Denver Launches Rockflowr Retail with Acquisition of Royal Green
Denver, Colorado--(Newsfile Corp. - February 10, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), Cultivator, Distributor of CBD and...
NextGen Healthcare Recognized a Forbes Best Employer
Company Ranked a Top Midsize Employer in Nationwide Survey ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of...
Feinstein Institutes Names Dr. Anil K. Malhotra Co-Director of the Institute of Behavioral Science
MANHASSET, N.Y.--(BUSINESS WIRE)--The Feinstein Institutes for Medical Research, the research home of Northwell Health, has named Anil K. Malhotra, MD,...
BENSON HILL LAUNCHES TRUVAIL™ SOY PROTEIN INGREDIENT PORTFOLIO FEATURING UNIQUE SUSTAINABILITY BENEFITS FOR BROAD FOOD APPLICATION
ST. LOUIS, Feb. 10, 2022 /PRNewswire/ -- Benson Hill, Inc. (NYSE: BHIL, the "Company" or "Benson Hill"), a food tech company...
Hospice of Westchester Announces Expansion of Shereff Family’s Sponsorship
WHITE PLAINS, NY / ACCESSWIRE / February 10, 2022 / Hospice of Westchester (HOW) is pleased to announce the expansion...
Empower Clinics Signs Partnership with One of North America’s Largest Terminal Operators to Provide COVID Testing Services
Partnership with CERES Terminals Canada Supporting the safe return of the cruise ship industry to Vancouver with more than 1,200,000...
Jaguar Health Completes Final Major Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs
Canalevia™ would be first and only FDA-approved plant-based medicine for working dogs that suffer from diarrheaSAN FRANCISCO, CA / ACCESSWIRE...
BIO-Europe Spring(R) Remains Europe’s Largest and Most International Biopharma Industry Gathering this Spring
Statistics show half of all meetings are already agreed upon 2 weeks before the eventMUNICH, GERMANY / ACCESSWIRE / February...
Avant Brands Announces Timing of Release of 2021 Annual Results and Conference Call
KELOWNA, BC / ACCESSWIRE / February 10, 2022 / Avant Brands Inc. (TSX:AVNT) (OTCQX:AVTBF) (FRA:1BUP) ("Avant" or the "Company"), an...
Dynatronics Corporation Reports Second Quarter Financial Results and Business Highlights
EAGAN, MN / ACCESSWIRE / February 10, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
CureVac Doses First Participant in Phase 1 Study with Multivalent Influenza Vaccine Candidate Based on Second-Generation mRNA Backbone Developed in Collaboration with GSK
- Multivalent technology approach for seasonal influenza mRNA vaccine candidate addressing four different influenza strains- Influenza candidate developed in collaboration...
Latina-Led Respira Labs Raises $2.8 Million to Revolutionize Respiratory Care for COPD, COVID-19 and Asthma Patients
The funding is a major win for a standout medtech startup and U.S. Latinx startup community; allows the company to...
Vericel to Report Fourth-Quarter 2021 Financial Results on February 24, 2022
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
BRISBANE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”) (Nasdaq: VERA), a late-stage biotechnology company focused on...
Vaxcyte to Present at the 11th Annual SVB Leerink Global Healthcare Conference
SAN CARLOS, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines...
Dyadic and Phibro Animal Health Announce Exclusive License Agreement to Develop and Commercialize Animal Health Vaccine
The exclusive license agreement between Dyadic and Phibro utilizes Dyadic engineered C1-cells to produce specific targeted antigens for development and...
TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be presenting at...
ALR Technologies Announces Completion of Continuous Glucose Monitor (CGM) Integration and Provides Update on Human Initiatives
SINGAPORE, Feb. 10, 2022 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, today...
Outlook Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Live video webcast presentation on Friday, February 18th at 10:40 AM ETISELIN, N.J., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Outlook...